76 – 85 of 85
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction
(
- Contribution to journal › Article
- 2015
-
Mark
Type 2 myocardial infarction in clinical practice.
(
- Contribution to journal › Article
-
Mark
Replik till Åke Thörn och Bengt Järhult: - Seriös diskussion om kvalitetsregister välkomnas
(
- Contribution to journal › Letter
-
Mark
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
(
- Contribution to journal › Article
- 2014
-
Mark
Delay From First Medical Contact to Primary PCI and All-Cause Mortality: A Nationwide Study of Patients With ST-Elevation Myocardial Infarction.
(
- Contribution to journal › Article
-
Mark
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction.
(
- Contribution to journal › Article
-
Mark
DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial.
(
- Contribution to journal › Article
-
Mark
SWEDEHEART Annual Report 2012
(
- Contribution to journal › Article
-
Mark
Swedeheart : Annual Report 2013
2014)(
- Book/Report › Report
- 2013
-
Mark
The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).
(
- Contribution to journal › Article